Modified Albumin-Bilirubin Grade optimized for risk stratification of patients with stage II-III gastric cancer.
Shoka M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Shimizu D, Tanaka C, Fujiwara M, Murotani K, Kodera Y.
Shoka M, et al. Among authors: matsushita h.
Surg Today. 2023 Oct;53(10):1149-1159. doi: 10.1007/s00595-023-02669-x. Epub 2023 Mar 24.
Surg Today. 2023.
PMID: 36961609